HOE-642 improves the protection of hypothermia on neuronal mitochondria after cardiac arrest in rats.

Lanying Wei, Pengjiao Zhang, Yanan Hu, Wenshuai Zhao, Xintong Liu, Xifan Wang, Fei Han

Open access · greenAbstract read

In one paragraph

Article in American journal of translational research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

0.7field-weighted citation impact, top 29% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

Linggui Zhugan Decoction activates the SIRT1-AMPK-PGC1α signaling pathway to improve mitochondrial and oxidative damage in rats with chronic heart failure caused by myocardial infarction.Frontiers in pharmacology · 2023
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Lanying WeiDepartment of Anesthesiology, The Third Affiliated Hospital, Harbin Medical University Harbin 150081, Heilongjiang, China.

Pengjiao ZhangDepartment of Anesthesiology, The Third Affiliated Hospital, Harbin Medical University Harbin 150081, Heilongjiang, China.

Yanan HuDepartment of Anesthesiology, The Third Affiliated Hospital, Harbin Medical University Harbin 150081, Heilongjiang, China.

Wenshuai ZhaoDepartment of Anesthesiology, The Third Affiliated Hospital, Harbin Medical University Harbin 150081, Heilongjiang, China.

Xintong LiuDepartment of Anesthesiology, The Third Affiliated Hospital, Harbin Medical University Harbin 150081, Heilongjiang, China.

Xifan WangDepartment of Anesthesiology, The Third Affiliated Hospital, Harbin Medical University Harbin 150081, Heilongjiang, China.

Fei HanDepartment of Anesthesiology, The Third Affiliated Hospital, Harbin Medical University Harbin 150081, Heilongjiang, China.

Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

HOE-642 has been shown to provide significant protection in a variety of models of cerebral and myocardial ischemia/reperfusion injury. In this study, we examined the impact of HOE-642, a selective Na

Indexed as

CPRHOE642hypothermiaischemia/reperfusionmitochondrianeuroprotection

Identifiers

PMID32509210

PMCPMC7270008

OpenAlexW3033526191

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.